We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
-1.43%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.94B
AUM Growth
-$39.1M
Cap. Flow
+$3.2M
Cap. Flow %
0.16%
Top 10 Hldgs %
31.51%
Holding
348
New
24
Increased
157
Reduced
133
Closed
21
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VONG icon
176
Vanguard Russell 1000 Growth ETF
VONG
$42.3B
$1M 0.05%
9,714
-584
-6% -$59.1K
HYG icon
177
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$993K 0.05%
12,631
+1,569
+14% +$125K
LLY icon
178
Eli Lilly
LLY
$1.07T
$991K 0.05%
1,283
-64
-5% -$53K
SPMB icon
179
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.98B
$989K 0.05%
45,908
+78
+0.2% +$1.71K
GOOG icon
180
Alphabet (Google) Class C
GOOG
$3.99T
$882K 0.05%
4,631
+347
+8% +$61.2K
INFL icon
181
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.49B
$858K 0.04%
22,540
-1,250
-5% -$50K
SUSC icon
182
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$829K 0.04%
36,476
-1,568
-4% -$36.3K
XLC icon
183
State Street Communication Services Select Sector SPDR ETF
XLC
$22.1B
$807K 0.04%
8,332
+53
+0.6% +$5.05K
AMLP icon
184
Alerian MLP ETF
AMLP
$12.7B
$803K 0.04%
16,665
CGDV icon
185
Capital Group Dividend Value ETF
CGDV
$37.2B
$801K 0.04%
22,718
+1,083
+5% +$39.4K
MOAT icon
186
VanEck Morningstar Wide Moat ETF
MOAT
$11.7B
$791K 0.04%
8,531
+104
+1% +$10K
PULS icon
187
PGIM Ultra Short Bond ETF
PULS
$17.7B
$787K 0.04%
15,882
+10,414
+190% +$517K
TMO icon
188
Thermo Fisher Scientific
TMO
$208B
$781K 0.04%
1,502
-2
-0.1% -$1.1K
ESGE icon
189
iShares ESG Aware MSCI EM ETF
ESGE
$6.53B
$777K 0.04%
23,265
-234
-1% -$8.26K
BUFR icon
190
FT Vest Fund of Buffer ETFs
BUFR
$10.1B
$754K 0.04%
24,755
+1,989
+9% +$60.3K
ORCL icon
191
Oracle
ORCL
$345B
$741K 0.04%
4,444
+48
+1% +$8.53K
SPHY icon
192
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
$739K 0.04%
31,483
-4,400
-12% -$104K
PG icon
193
Procter & Gamble
PG
$346B
$727K 0.04%
4,336
-10
-0.2% -$1.7K
JNJ icon
194
Johnson & Johnson
JNJ
$641B
$722K 0.04%
4,989
-155
-3% -$24K
COST icon
195
Costco
COST
$422B
$721K 0.04%
787
+21
+3% +$19.5K
AOR icon
196
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$720K 0.04%
12,568
-274
-2% -$16K
SHV icon
197
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$716K 0.04%
6,506
+180
+3% +$19.8K
WMT icon
198
Walmart Inc
WMT
$889B
$713K 0.04%
7,889
-955
-11% -$82.9K
DE icon
199
Deere & Co
DE
$169B
$709K 0.04%
1,673
-9
-0.5% -$3.79K
ADM icon
200
Archer Daniels Midland
ADM
$40.1B
$696K 0.04%
13,783
-29,900
-68% -$1.62M

Similar funds

Trilogy Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Trilogy Capital held 348 positions worth $1.94B, down 2% from $1.98B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trilogy Capital's Q4 2024 filing shows 24 new, 157 increased, 133 reduced and 21 closed positions. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 29,805 shares worth $12.7M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $18.7M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Financials and Healthcare.

  • Trilogy Capital's largest Q4 2024 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 29,805 shares worth $12.7M.
  • Trilogy Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $12.9M increase.
  • Trilogy Capital's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $18.7M.
  • Trilogy Capital fully exited State Street Materials Select Sector SPDR ETF in Q4 2024, selling an estimated $5.13M.
  • Trilogy Capital's ten largest holdings make up 32% of its $1.94B portfolio in Q4 2024.
  • Trilogy Capital opened 24 new positions and closed 21 in Q4 2024.
  • Trilogy Capital's portfolio value fell 2% quarter-over-quarter to $1.94B.

Based on Trilogy Capital's 13F filing for Q4 2024, filed 27 Jan 2025.